Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 — Trials · CancerIndex

Clinical trials

Registered studies

166 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: City of Hope Medical Center
Termination share: 29.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02105116	AML Therapy With Irradiated Allogeneic Cells	terminated	N/A	6	Rutgers, The State University of New JerseyOTHER	1	Aug 24, 2021	clinicaltrials
NCT01076270	Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	terminated	N/A	1	Fred Hutchinson Cancer CenterOTHER	1	Jun 28, 2017